MD Anderson and National Resilience launch the Cell Therapy Manufacturing Center

By | June 2, 2022
The University of Texas MD Anderson Cancer Center and National Resilience, Inc., today announced the launch of a joint venture, the Cell Therapy Manufacturing Center, to accelerate the development and manufacturing of innovative cell therapies for patients with cancer.